Optical isomers
US4981858A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 18, 1989 |
| Grant date | Jan 1, 1991 |
| Priority date | — |
| Expiry date | Apr 18, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D497/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The (+)-cis-, (-)-cis-, (+)-trans- and (-)-trans- forms of 2-methylspiro(1,3-oxathiolan-5,3')quinuclidine are prepared by optical resolution of each of the (.+-.)-cis- and (.+-.)-trans-isomers. These compounds find application in treating diseases of the central nervous system in mammals, especially diseases due to a deficiency in the central cholinergic system. Biological tests indicate that the (-)-cis-form, as well as the (.+-.)-cis-isomer, shows particular promise for treating senile dementia of Alzheimer's type.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.